Monday, November 2, 2026

MONSTA X’s Kihyun Returns: What to Expect from His New Mini Album BORDERLINE?

MONSTA X's Kihyun returns with his mini-album "BORDERLINE," showcasing musical maturity after a four-year hiatus.

North Korea’s Missile Fizzles Out, Exploding Over the Sea

North Korea launched a ballistic missile into the East Sea early on the morning of the 26th, but it failed to complete a routine flight.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

Seers Signs $14.7 Million Contract with UAE to Supply 105,000 Units over 3 Years

Seers signs a major deal for mobiCARE devices in the UAE, aiming for 50% growth and expansion into Vietnam and beyond.

Yonsei University Develops AI Platform for Early Autism Screening and Treatment

Yonsei University is developing an AI platform for autism screening, aiming for early detection and practical use in clinical settings.

Mediwhale’s DrNoon Receives CE MDR Certification in Europe for Cardiovascular Risk Prediction

Mediwheel's retinal AI solution 'DrNoon' has received CE MDR certification, enhancing its credibility in the European medical device market.

Korean MSD Partners with 13 Biotech Firms to Act as Global Collaboration Hub

Korean MSD held an Open Innovation Week to enhance collaboration with local biotech firms, aiming for technology exchanges and joint research.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

AITRICS Showcases Clinical Value and Real-World Applications of AITRICS-VC (VitalCare) Solution

AITRICS showcased its VitalCare AI solution for predicting critical health conditions at a symposium, enhancing clinical decision-making.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

VAIM Hosts JUVELOOK and juveàcell Symposium in Busan for Aesthetic Medicine and Treatment

VAIM hosted the JUVELOOK & juveàcell Symposium in Busan, showcasing advancements in aesthetic medicine for healthcare providers.

Curocell’s RIMQARTO®: The First CAR-T Therapy in Korea, with Plans for Global Release

Curocell aims to lead in CAR-T therapies with RIMQARTO's approval, focusing on solid tumors and global expansion strategies.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

AITRICS: “Medical Artificial Intelligence (AI) is No Longer a Choice”

Medical AI must prove its real-world value. AITRICS focuses on tools that enhance decision-making and integrate into healthcare workflows.

Top News

- Our Sponsors Ad -

Follow us